comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 19:27:59 - browse：757

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Study finds new variant for Parkinson’s in African populations

entertainment

knowledge

WSS

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Australia’s approach to dialysis celebrates life

Appeals court upholds limits to abortion pill

A Greenpeace activist is fined for crash

A Greenpeace activist is fined for crash

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

focus

comprehensive

focus

Guidelines to prevent youth baseball injuries need more muscle

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Bright Health sells Medicare Advantage business to Molina

2024 GOP presidential candidates spar over abortion in debate

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

DIEP, the 'gold standard' of breast reconstruction, is under threat

After half a century, Israel moves to evict squatter from his cave home on the beach

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

EU fines Illumina $475 million over Grail acquisition

explore

Companies helping big Covid

Superbugs, antibiotic resistance get scrutiny in congress

Psilocybin's anti

What AAP's gender

A Greenpeace activist is fined for crash

Grail's uphill battle for Medicare to cover its cancer screening test

entertainment

knowledge

Wikipedia

Wikipedia